Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-022-28533-z, published online 16 February 2022.
In this article the affiliation ‘Infectious Disease Translational Research Programme, National University of Singapore, 117597, Singapore’ for Justin Jang Hann Chu was missing. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The article to which this update relates has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1038/s41467-023-36751-2
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gunaseelan, S., Ariffin, M.Z., Khanna, S. et al. Author Correction: Pharmacological perturbation of CXCL1 signaling alleviates neuropathogenesis in a model of HEVA71 infection. Nat Commun 13, 1693 (2022). https://doi.org/10.1038/s41467-022-29362-w
Published:
DOI: https://doi.org/10.1038/s41467-022-29362-w
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
